Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: CTN010
MIFTS: 28

Cutaneous Ganglioneuroma

Categories: Cancer diseases, Skin diseases
Genes Tissues Related diseases Publications Pathways
Sources

Aliases & Classifications for Cutaneous Ganglioneuroma

About this section

MalaCards integrated aliases for Cutaneous Ganglioneuroma:

Name: Cutaneous Ganglioneuroma 12 15
Ganglioneuroma of Skin 12 71

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Skin diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:2425
NCIt 49 C4481
UMLS 71 C0346063
Sources

Summaries for Cutaneous Ganglioneuroma

About this section
MalaCards based summary : Cutaneous Ganglioneuroma, also known as ganglioneuroma of skin, is related to gangliocytoma and ganglioneuroma. An important gene associated with Cutaneous Ganglioneuroma is CNP (2',3'-Cyclic Nucleotide 3' Phosphodiesterase), and among its related pathways/superpathways are Neuroscience and Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include skin, lung and breast, and related phenotypes are cellular and nervous system

Sources

Related Diseases for Cutaneous Ganglioneuroma

About this section

Diseases related to Cutaneous Ganglioneuroma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 314, show less)
# Related Disease Score Top Affiliating Genes
1 gangliocytoma 30.8 SYP CHGA
2 ganglioneuroma 30.3 SYP NCAM1 ENO2 CHGA
3 thyroid gland medullary carcinoma 29.7 SYP ENO2 CHGA
4 neurofibroma 28.6 SYP MITF KIT CNP CD34
5 neuroblastoma 28.1 SYP NCAM1 KIT ENO2 CHGA APP
6 vulvar apocrine adenocarcinoma 10.4 KRT20 ENO2
7 vaginal glandular tumor 10.3 ENO2 CHGA
8 choriocarcinoma of ovary 10.3 NCAM1 ENO2
9 breast rhabdomyosarcoma 10.3 NCAM1 ENO2
10 gastric gastrinoma 10.3 ENO2 CHGA
11 malignant melanocytic neoplasm of the peripheral nerve sheath 10.3 SYP ENO2
12 bile duct adenoma 10.3 NCAM1 KRT20
13 eyelid benign neoplasm 10.3 KRT20 CHGA
14 penis sarcoma 10.3 ENO2 CD34
15 sinonasal undifferentiated carcinoma 10.3 SYP ENO2
16 cerebral neuroblastoma 10.3 SYP ENO2
17 angiomyoma 10.3 ENO2 CD34
18 pacinian tumor 10.3 ENO2 CD34
19 papillary tumor of the pineal region 10.3 SYP ENO2
20 middle cerebral artery infarction 10.3 NCAM1 ENO2
21 intracranial primitive neuroectodermal tumor 10.3 SYP ENO2
22 bile duct mucinous adenocarcinoma 10.3 SYP ENO2
23 nodular prostate 10.3 SYP ENO2
24 cloacogenic carcinoma 10.3 SYP ENO2
25 appendix lymphoma 10.3 ENO2 CHGA
26 female urethral cancer 10.3 KRT20 CHGA
27 angiomatous meningioma 10.3 ENO2 CD34
28 mature teratoma of the ovary 10.3 SYP ENO2
29 extraosseous ewings sarcoma-primitive neuroepithelial tumor 10.3 SYP ENO2
30 lung combined type small cell carcinoma 10.3 SYP NCAM1
31 spindle cell thymoma 10.3 ENO2 CD34
32 jejunal cancer 10.3 KRT20 CHGA
33 cerebellar liponeurocytoma 10.2 SYP ENO2
34 papillary ependymoma 10.2 SYP ENO2
35 optic nerve astrocytoma 10.2 SYP ENO2
36 hypoganglionosis 10.2 SYP NCAM1
37 frontal lobe neoplasm 10.2 SYP ENO2
38 pineal parenchymal tumor of intermediate differentiation 10.2 SYP ENO2
39 mucinous bronchioloalveolar adenocarcinoma 10.2 KRT20 ENO2
40 adrenal neuroblastoma 10.2 SYP ENO2
41 aortic malignant tumor 10.2 KRT20 CD34
42 glycogen-rich clear cell breast carcinoma 10.2 SYP KRT20
43 congenital granular cell tumor 10.2 ENO2 CD34
44 extraskeletal ewing sarcoma 10.2 SYP ENO2
45 vulvar leiomyoma 10.2 NCAM1 CD34
46 rhabdoid meningioma 10.2 SYP ENO2
47 spinal cord oligodendroglioma 10.2 SYP ENO2
48 colonic lymphangioma 10.2 KRT20 CD34
49 krukenberg carcinoma 10.2 SYP KRT20
50 biliary tract benign neoplasm 10.2 SYP NCAM1
51 endobronchial lipoma 10.2 SYP ENO2
52 cerebellar medulloblastoma 10.2 SYP ENO2
53 cerebrovascular benign neoplasm 10.2 SYP ENO2
54 clear cell ependymoma 10.2 SYP ENO2
55 appendix adenocarcinoma 10.2 SYP KRT20
56 extraosseous ewing sarcoma 10.2 SYP ENO2
57 cerebellum cancer 10.2 SYP ENO2
58 clear cell basal cell carcinoma 10.2 KRT20 CHGA
59 keratosis, seborrheic 10.2
60 keratosis 10.2
61 inverted follicular keratosis 10.2
62 pineal gland cancer 10.2 SYP ENO2
63 central nervous system primitive neuroectodermal neoplasm 10.2 SYP ENO2
64 thyroid angiosarcoma 10.2 KRT20 CD34
65 askin's tumor 10.2 SYP ENO2
66 primary hepatic neuroendocrine carcinoma 10.2 SYP CHGA
67 pancreas lymphoma 10.2 SYP CHGA
68 adenoid squamous cell carcinoma 10.2 KRT20 CD34
69 acinar cell cystadenocarcinoma 10.2 SYP CHGA
70 vulvar eccrine porocarcinoma 10.2 SYP CHGA
71 gastrointestinal neuroendocrine benign tumor 10.2 SYP CHGA
72 ependymoblastoma 10.2 SYP ENO2
73 mixed ductal-endocrine carcinoma 10.2 SYP CHGA
74 vulvar benign neoplasm 10.2 NCAM1 CD34
75 breast papillary carcinoma 10.2 SYP CHGA
76 melanotic neuroectodermal tumor 10.2 SYP ENO2
77 gastric neuroendocrine neoplasm 10.1 SYP CHGA
78 cervical neuroblastoma 10.1 SYP CHGA
79 scleredema adultorum 10.1 NCAM1 CD34
80 pancreatic gastrinoma 10.1 SYP CHGA
81 sclerosing hepatic carcinoma 10.1 CHGA CD34
82 subleukemic leukemia 10.1 SYP ENO2
83 gastrointestinal neuroendocrine tumor 10.1 SYP CHGA
84 adult xanthogranuloma 10.1 MITF CD34
85 lung meningioma 10.1 SYP CD34
86 epithelioid malignant peripheral nerve sheath tumor 10.1 CHGA CD34
87 glomangiosarcoma 10.1 SYP CD34
88 lung clear cell carcinoma 10.1 SYP CHGA
89 pancreatic acinar cell adenocarcinoma 10.1 SYP CHGA
90 extra-adrenal pheochromocytoma 10.1 SYP CHGA
91 astroblastoma 10.1 SYP ENO2
92 middle ear carcinoma 10.1 SYP CHGA
93 ischemic fasciitis 10.1 KRT20 CD34
94 lymphoepithelioma-like carcinoma 10.1 KRT20 ENO2
95 benign perivascular tumor 10.1 SYP CD34
96 ganglioneuroblastoma 10.1 SYP GNS ENO2
97 spinal cancer 10.1 SYP ENO2
98 goblet cell carcinoid 10.1 KRT20 ENO2 CHGA
99 dermis tumor 10.1 MITF CD34
100 obstructive hydrocephalus 10.1 SYP ENO2
101 anal neuroendocrine tumor 10.0 SYP NCAM1 ENO2
102 myxopapillary ependymoma 10.0 SYP NCAM1
103 bone benign neoplasm 10.0 SYP ENO2
104 cerebellopontine angle primitive neuroectodermal 10.0 SYP NCAM1 ENO2
105 rare tumor 10.0
106 orbital cancer 10.0 NCAM1 ENO2 CD34
107 nasal cavity olfactory neuroblastoma 10.0 SYP NCAM1 ENO2
108 supratentorial primitive neuroectodermal tumor 10.0 SYP NCAM1 ENO2
109 pulmonary artery leiomyosarcoma 10.0 KRT20 ENO2 CD34
110 oligodendroglioma 10.0 SYP ENO2 CNP
111 cystic basal cell carcinoma 10.0 SYP KRT20 ENO2
112 benign teratoma 10.0 SYP KRT20 ENO2
113 adrenal medulla cancer 10.0 SYP CHGA
114 skin benign neoplasm 10.0 KRT20 ENO2 CD34
115 epithelioid cell synovial sarcoma 10.0 SYP CD34
116 intratubular embryonal carcinoma 10.0 KRT20 KIT
117 fibrous histiocytoma 10.0 MITF ENO2 CD34
118 cerebral ventricle cancer 10.0 SYP ENO2
119 medulloepithelioma 10.0 SYP KRT20
120 mucinous stomach adenocarcinoma 10.0 KRT20 KIT
121 appendix carcinoid tumor 10.0 SYP ENO2 CHGA
122 auditory system cancer 10.0 SYP ENO2 CHGA
123 thymus small cell carcinoma 10.0 SYP ENO2 CHGA
124 cauda equina neoplasm 10.0 SYP ENO2 CHGA
125 duodenal benign neoplasm 10.0 SYP ENO2 CHGA
126 ampulla of vater neoplasm 10.0 SYP ENO2 CHGA
127 middle ear adenoma 10.0 SYP ENO2 CHGA
128 nodular ganglioneuroblastoma 10.0 SYP ENO2 CHGA
129 carotid body cancer 10.0 SYP ENO2 CHGA
130 sensory organ benign neoplasm 10.0 SYP ENO2 CHGA
131 pineocytoma 10.0 SYP ENO2 CHGA
132 lung oat cell carcinoma 10.0 SYP ENO2 CHGA
133 cervix small cell carcinoma 10.0 SYP ENO2 CHGA
134 carcinoid tumors, intestinal 9.9 SYP ENO2 CHGA
135 thymus clear cell carcinoma 9.9 KRT20 KIT
136 colon neuroendocrine neoplasm 9.9 SYP ENO2 CHGA
137 carcinoid syndrome 9.9 SYP ENO2 CHGA
138 olfactory neuroblastoma 9.9 SYP ENO2 CHGA
139 granulosa cell tumor of the ovary 9.9 SYP ENO2 CHGA
140 laryngeal neuroendocrine tumor 9.9 SYP NCAM1 CHGA
141 pulmonary sclerosing hemangioma 9.9 SYP ENO2 CHGA
142 sclerosing hemangioma 9.9 SYP ENO2 CHGA
143 papillary thymic adenocarcinoma 9.9 SYP NCAM1 CHGA
144 microcystic adenoma 9.9 SYP ENO2 CHGA
145 esophageal adenoid cystic carcinoma 9.9 SYP NCAM1 CHGA
146 central neurocytoma 9.9 SYP ENO2 CHGA
147 cerebrum cancer 9.9 SYP ENO2
148 adrenal cortical adenoma 9.9 SYP ENO2 CHGA
149 pulmonary large cell neuroendocrine carcinoma 9.9 SYP NCAM1 CHGA
150 laryngeal small cell carcinoma 9.9 SYP NCAM1 CHGA
151 esophageal neuroendocrine tumor 9.9 SYP NCAM1 CHGA
152 islet cell tumor 9.9 SYP ENO2 CHGA
153 pulmonary neuroendocrine tumor 9.9 SYP NCAM1 CHGA
154 pancreatic endocrine carcinoma 9.9 SYP NCAM1 CHGA
155 vaginal tubulovillous adenoma 9.9 SYP KRT20 CHGA
156 lung large cell carcinoma 9.9 SYP NCAM1 CHGA
157 vaginal adenoma 9.9 SYP KRT20 CHGA
158 ganglioglioma 9.9 SYP ENO2 CHGA
159 pancreatoblastoma 9.9 SYP CHGA
160 vaginal benign neoplasm 9.9 SYP KRT20 CHGA
161 primary pigmented nodular adrenocortical disease 9.9 SYP NCAM1 CHGA
162 endocrine organ benign neoplasm 9.9 SYP ENO2 CHGA
163 adrenal carcinoma 9.9 SYP ENO2 CHGA
164 spinal cord sarcoma 9.9 KIT CD34
165 supratentorial cancer 9.9 SYP ENO2
166 gallbladder leiomyoma 9.9 KIT CD34
167 bladder leiomyoma 9.9 KIT CD34
168 vaginal endometrial stromal sarcoma 9.9 SYP ENO2 CD34
169 dowling-degos disease 1 9.9 MITF KIT
170 breast hemangiopericytoma 9.9 KIT CD34
171 small intestinal sarcoma 9.9 KIT CD34
172 small intestine leiomyosarcoma 9.9 KIT CD34
173 colon leiomyosarcoma 9.9 KIT CD34
174 extraosseous chondrosarcoma 9.9 SYP ENO2 CD34
175 thyroid carcinoma, familial medullary 9.9
176 neurofibromatosis, type iv, of riccardi 9.9
177 nevus, epidermal 9.9
178 microphthalmia 9.9
179 glomus tumor 9.9 SYP ENO2 CD34
180 gallbladder leiomyosarcoma 9.9 KIT CD34
181 deep leiomyoma 9.9 KIT CD34
182 mature teratoma 9.9 SYP KIT
183 heart leiomyosarcoma 9.9 KIT CD34
184 hemangioblastoma 9.9 SYP ENO2 CD34
185 esophagus sarcoma 9.9 KIT CD34
186 papillary carcinoma 9.9 SYP KRT20 CHGA
187 small intestine leiomyoma 9.9 KIT CD34
188 liver leiomyoma 9.9 KIT CD34
189 retroperitoneal leiomyosarcoma 9.9 KIT CD34
190 central epithelioid sarcoma 9.9 SYP KRT20 CD34
191 vulvar proximal-type epithelioid sarcoma 9.9 SYP KRT20 CD34
192 papilloma of choroid plexus 9.9 SYP ENO2
193 hypomelanosis of ito 9.8 MITF KIT
194 bladder benign neoplasm 9.8 KRT20 KIT
195 breast malignant phyllodes tumor 9.8 KIT CD34
196 retroperitoneal sarcoma 9.8 KIT CD34
197 gliosarcoma 9.8 SYP ENO2 CD34
198 mesenchymoma 9.8 KIT CD34
199 uterus leiomyosarcoma 9.8 KIT CD34
200 nodular malignant melanoma 9.8 MITF KIT
201 waardenburg syndrome, type 4b 9.8 MITF KIT
202 ovarian germ cell cancer 9.8 SYP KIT
203 clear cell meningioma 9.8 SYP CHGA CD34
204 colon sarcoma 9.8 KIT CD34
205 adult mesoblastic nephroma 9.8 KIT CD34
206 bladder lateral wall cancer 9.8 SYP NCAM1 KRT20 ENO2
207 heart cancer 9.8 KIT CD34
208 dysgerminoma 9.8 KRT20 KIT ENO2
209 tuberous sclerosis 9.8 SYP ENO2 CHGA
210 binswanger's disease 9.7 SYP CHGA APP
211 ureter small cell carcinoma 9.7 SYP NCAM1 ENO2 CHGA
212 gastric small cell carcinoma 9.7 SYP NCAM1 ENO2 CHGA
213 subependymoma 9.7 SYP NCAM1 ENO2 CHGA
214 cervical large cell neuroendocrine carcinoma 9.7 SYP NCAM1 ENO2 CHGA
215 gallbladder small cell carcinoma 9.7 SYP NCAM1 ENO2 CHGA
216 olfactory nerve neoplasm 9.7 SYP NCAM1 ENO2 CHGA
217 cranial nerve malignant neoplasm 9.7 SYP NCAM1 ENO2 CHGA
218 cranial nerve neoplasm 9.7 SYP NCAM1 ENO2 CHGA
219 malignant pheochromocytoma 9.7 SYP NCAM1 ENO2 CHGA
220 subependymal giant cell astrocytoma 9.7 SYP NCAM1 ENO2 CHGA
221 vulvar disease 9.7 KIT CD34
222 small cell carcinoma of the bladder 9.7 SYP KRT20 ENO2 CHGA
223 horseshoe kidney 9.7 SYP KRT20 ENO2 CHGA
224 basaloid squamous cell carcinoma 9.7 SYP KRT20 ENO2 CHGA
225 plexiform schwannoma 9.7 KIT ENO2 CD34
226 retroperitoneal hemangiopericytoma 9.7 KIT ENO2 CD34
227 ovarian large-cell neuroendocrine carcinoma 9.7 SYP NCAM1 KRT20 CHGA
228 breast leiomyosarcoma 9.7 KIT ENO2 CD34
229 conventional fibrosarcoma 9.7 KIT ENO2 CD34
230 neurofibrosarcoma 9.7 KIT ENO2 CD34
231 connective tissue benign neoplasm 9.7 KIT ENO2 CD34
232 pick disease of brain 9.6 SYP CHGA APP
233 lymphoepithelioma-like thymic carcinoma 9.6 SYP NCAM1 KIT
234 myeloid sarcoma 9.6 NCAM1 KIT CD34
235 inflammatory myofibroblastic tumor 9.6 KIT ENO2 CD34
236 dermatofibrosarcoma protuberans 9.6 KIT ENO2 CD34
237 lymphatic system cancer 9.6 NCAM1 KIT CD34
238 thymoma 9.6 SYP KIT ENO2
239 colorectal adenocarcinoma 9.6 KRT20 KIT CHGA
240 lymphatic system disease 9.6 NCAM1 KIT CD34
241 chromophobe renal cell carcinoma 9.6 KRT20 KIT CHGA
242 intestinal obstruction 9.6 KRT20 KIT CD34
243 malignant spindle cell melanoma 9.6 MITF KIT CD34
244 perivascular epithelioid cell tumor 9.6 SYP MITF KIT
245 bone marrow cancer 9.6 NCAM1 KIT CD34
246 oncocytoma 9.6 SYP KRT20 KIT
247 pelvic lipomatosis 9.6 SYP ENO2 CHGA CD34
248 respiratory system benign neoplasm 9.6 SYP ENO2 CHGA CD34
249 cardiovascular organ benign neoplasm 9.6 SYP ENO2 CHGA CD34
250 meckel diverticulum 9.6 KIT CHGA CD34
251 creutzfeldt-jakob disease 9.6 SYP ENO2 APP
252 spindle cell carcinoma 9.6 SYP ENO2 CHGA CD34
253 chordoid meningioma 9.6 SYP NCAM1 CHGA CD34
254 autonomic nervous system neoplasm 9.6 SYP NCAM1 ENO2 APP
255 perineurioma 9.5 NCAM1 KIT
256 leukocyte disease 9.5 NCAM1 KIT CD34
257 pancytopenia 9.5 NCAM1 KIT CD34
258 cecal disease 9.5 SYP CHGA
259 gliofibroma 9.5 SYP KIT CD34
260 cell type benign neoplasm 9.5 SYP KIT CD34
261 malignant teratoma 9.5 SYP S100A6 KIT ENO2
262 urinary bladder small cell neuroendocrine carcinoma 9.4 SYP NCAM1 KRT20 ENO2 CHGA
263 prostate neuroendocrine neoplasm 9.4 SYP NCAM1 KRT20 ENO2 CHGA
264 breast neuroendocrine neoplasm 9.4 SYP NCAM1 KRT20 ENO2 CHGA
265 tubular adenocarcinoma 9.4 SYP NCAM1 KRT20 ENO2 CHGA
266 lung benign neoplasm 9.4 SYP NCAM1 KRT20 ENO2 CHGA
267 neuroendocrine tumor 9.4 SYP NCAM1 KRT20 ENO2 CHGA
268 cystic teratoma 9.4 SYP KRT20 KIT ENO2
269 thymic carcinoma 9.4 SYP KRT20 KIT ENO2
270 clear cell sarcoma 9.4 SYP MITF KIT ENO2
271 malignant peripheral nerve sheath tumor 9.4 S100A6 MITF KIT CD34
272 histiocytoma 9.4 MITF KIT ENO2 CD34
273 neurilemmoma 9.4 MITF KIT ENO2 CD34
274 autonomic nervous system benign neoplasm 9.4 SYP GNS ENO2 CHGA CD34
275 peripheral nervous system benign neoplasm 9.4 SYP GNS ENO2 CHGA CD34
276 central nervous system benign neoplasm 9.4 SYP GNS ENO2 CHGA CD34
277 liver leiomyosarcoma 9.3 KIT ENO2 CHGA CD34
278 small intestine benign neoplasm 9.3 SYP KIT ENO2 CHGA
279 endobronchial leiomyoma 9.3 SYP KIT ENO2 CD34
280 vagina sarcoma 9.3 SYP KIT ENO2 CD34
281 cystadenoma 9.3 SYP KRT20 KIT CHGA
282 hemangiopericytoma, malignant 9.3 SYP KIT ENO2 CD34
283 mixed cell type cancer 9.3 SYP KIT ENO2 CD34
284 chondrosarcoma, extraskeletal myxoid 9.3 SYP KIT ENO2 CD34
285 skeletal muscle cancer 9.3 SYP KIT ENO2 CD34
286 muscle cancer 9.3 SYP KIT ENO2 CD34
287 prostate stromal sarcoma 9.3 SYP NCAM1 KIT CD34
288 meningioma, familial 9.3 SYP KIT ENO2 CD34
289 cavernous hemangioma 9.2 SYP KRT20 KIT CD34
290 cardiovascular cancer 9.2 SYP MITF KIT CD34
291 vascular cancer 9.2 SYP MITF KIT CD34
292 hirschsprung disease 1 9.1 SYP NCAM1 MITF KIT ENO2
293 endometrial small cell carcinoma 9.1 SYP NCAM1 KIT ENO2 CHGA
294 paraganglioma 9.1 SYP NCAM1 KIT ENO2 CHGA
295 suppression of tumorigenicity 12 9.1 SYP NCAM1 KIT ENO2 CHGA
296 teratoma 9.1 SYP KRT20 KIT ENO2 CHGA
297 jejunal neoplasm 9.0 SYP KRT20 KIT ENO2 CD34
298 wilms tumor 1 9.0 SYP NCAM1 KIT ENO2 CD34
299 basal cell carcinoma 9.0 SYP NCAM1 KRT20 KIT CD34
300 hemangioma 8.9 SYP KIT ENO2 CHGA CD34
301 glomangiomatosis 8.9 SYP NCAM1 KIT CHGA CD34
302 neuroendocrine carcinoma 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
303 large cell neuroendocrine carcinoma 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
304 small cell carcinoma 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
305 merkel cell carcinoma 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
306 large cell carcinoma 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
307 small cell cancer of the lung 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
308 pheochromocytoma 8.8 SYP NCAM1 MITF KIT ENO2 CHGA
309 leber congenital amaurosis 8.7 SYP NCAM1 KRT20 KIT ENO2 CD34
310 mediastinal cancer 8.7 SYP NCAM1 KIT ENO2 CHGA CD34
311 gastrointestinal stromal tumor 8.7 SYP NCAM1 KIT ENO2 CHGA CD34
312 ewing sarcoma 8.7 SYP NCAM1 KIT ENO2 CHGA CD34
313 peripheral nervous system neoplasm 8.6 SYP NCAM1 KIT ENO2 CD34 APP
314 muscular disease 8.5 SYP NCAM1 KIT ENO2 CD34 APP

Graphical network of the top 20 diseases related to Cutaneous Ganglioneuroma:



Diseases related to Cutaneous Ganglioneuroma
Sources

Symptoms & Phenotypes for Cutaneous Ganglioneuroma

About this section

MGI Mouse Phenotypes related to Cutaneous Ganglioneuroma:

45 (showing 2, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.56 APP CD34 CNP ENO2 GNS KIT
2 nervous system MP:0003631 9.28 APP CHGA CNP ENO2 GNS KIT
Sources

Drugs & Therapeutics for Cutaneous Ganglioneuroma

About this section

Search Clinical Trials , NIH Clinical Center for Cutaneous Ganglioneuroma

Sources

Genetic Tests for Cutaneous Ganglioneuroma

About this section
Sources

Anatomical Context for Cutaneous Ganglioneuroma

About this section

MalaCards organs/tissues related to Cutaneous Ganglioneuroma:

40
Skin, Lung, Breast, Small Intestine, Colon, Thyroid, Ovary
Sources

Publications for Cutaneous Ganglioneuroma

About this section

Articles related to Cutaneous Ganglioneuroma:

(showing 16, show less)
# Title Authors PMID Year
1
Cutaneous ganglioneuroma: A case report and discussion of the literature. 61
30632184 2019
2
Primary cutaneous ganglioneuroma: anatomico-clinical study of 4 cases with focus on Merkel cells. 61
29569258 2018
3
Ganglion cell like cells, diagnostic dilemma. 61
23919032 2013
4
Primary cutaneous ganglioneuroma of the finger mimicking verruca vulgaris: a case report. 61
22719011 2013
5
Acquired primary cutaneous ganglioneuroma with adipocytic metaplasia: "An end point of melanocytic 'maturation'?" a case report and meta-analysis with comparison to a cross-sectional study of neurotized melanocytic nevi. 61
21048488 2011
6
[Facial primary cutaneous ganglioneuroma]. 61
19364589 2009
7
Cutaneous ganglioneuroma associated with overlying hyperkeratotic epidermal changes: a report of 2 cases. 61
19033938 2008
8
Cutaneous ganglioneuroma. 61
17651174 2007
9
Primary cutaneous ganglioneuroma arising within a seborrheic keratosis: a rare association. 61
15725239 2005
10
Cutaneous ganglioneuroma within a giant congenital nevus. 61
24223002 2005
11
Primary cutaneous ganglioneuroma: a report of two cases and literature review. 61
12775986 2003
12
A case of cutaneous ganglioneuroma developing within a lesion of seborrheic keratosis. 61
12081162 2002
13
Desmoplastic cutaneous ganglioneuroma. 61
9934592 1999
14
Primary congenital cutaneous ganglioneuroma. 61
8698926 1996
15
Cutaneous ganglioneuromas: a case report and review of the literature. 61
8698321 1996
16
Cutaneous ganglion cell choristoma. Report of a case. 61
1774358 1991
Sources

Variations for Cutaneous Ganglioneuroma

About this section
Sources

Expression for Cutaneous Ganglioneuroma

About this section
Search GEO for disease gene expression data for Cutaneous Ganglioneuroma.
Sources

Pathways for Cutaneous Ganglioneuroma

About this section

Pathways related to Cutaneous Ganglioneuroma according to GeneCards Suite gene sharing:

(showing 4, show less)
# Super pathways Score Top Affiliating Genes
1
Neuroscience 4
11.56 SYP NCAM1 ENO2 CNP APP
2
Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers 64
11.5 NCAM1 KIT CD34
3
Innate Lymphoid Cell Differentiation Pathways 64
11.23 NCAM1 KIT CD34
4
Dendritic Cells Developmental Lineage Pathway 64
11 NCAM1 KIT CD34
Sources

GO Terms for Cutaneous Ganglioneuroma

About this section

Cellular components related to Cutaneous Ganglioneuroma according to GeneCards Suite gene sharing:

(showing 2, show less)
# Name GO ID Score Top Affiliating Genes
1 perinuclear region of cytoplasm GO:0048471 9.1 SYP S100A6 CNP CHGA CD34 APP
2 mast cell granule GO:0042629 8.96 KIT CHGA

Biological processes related to Cutaneous Ganglioneuroma according to GeneCards Suite gene sharing:

(showing 7, show less)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.67 MITF KIT CD34 APP
2 melanocyte differentiation GO:0030318 9.4 MITF KIT
3 axonogenesis GO:0007409 9.33 S100A6 CNP APP
4 regulation of long-term neuronal synaptic plasticity GO:0048169 9.32 SYP APP
5 mast cell degranulation GO:0043303 9.26 KIT CHGA
6 mast cell chemotaxis GO:0002551 8.96 KIT CHGA
7 mast cell cytokine production GO:0032762 8.62 KIT CHGA
Sources

Sources for Cutaneous Ganglioneuroma

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....